Proteus and Geneus Lab and data management solutions selected by University of Glasgow Genomics Facility and Rasor interdisciplinary research collaboration
GenoLogics reports that the University of Glasgow's Sir Henry Wellcome Functional Genomics Facility (SHWFGF), recently installed GenoLogics's Proteus for its proteomics research and will be adding Geneus to tackle its genomics research projects in the near future.
GenoLogics will provide the Sir Henry Wellcome Functional Genomics Facility and the Rasor interdisciplinary research collaboration with a solution for systems biology that enables a cross-science approach to genomics and proteomics research.
Andrew Pitt, director of the Sir Henry Wellcome Functional Genomics Facility and Rasor, stated, "We chose GenoLogics because of its partnering philosophy and commitment to systems biology and open standards, as well as its ability to customise a cross-science solution combining genomics and proteomics, with the promise of further developments in new fields.
"This will greatly enhance the productivity of the SHWFGF and our Rasor initiative.
"I'm increasingly convinced that it is crucial that software and database informatics technologies complement and accelerate the use of proteomics and genomics instrumentation and technologies in order to make research advances.
"GenoLogics integrates with our instruments and allows flexible workflows, which frees our researchers to focus on science rather than data management issues".
Michael Ball, GenoLogics CEO said, "We are very impressed with the range of technologies being developed in the Glasgow facility.
"We are particularly looking forward to their feedback once our new Geneus solution is installed and operating alongside Proteus, which will enable the facility to combine proteomics and gene expression data in real systems biology applications".
The University of Glasgow's Sir Henry Wellcome Functional Genomics Facility combines state-of-the-art technology and expertise in genomics, proteomics, tissue microanalysis, and bioinformatics with the aim of promoting biological and biomedical research by providing efficient service to the research community in Scotland and beyond.
Rasor, a GBP14million investment by the UK Research Councils and Scottish Funding Council, is a unique collaboration between the Universities of Glasgow, Dundee, Edinburgh, and Strathclyde with the purpose of designing new proteomics methods and equipment to solve cutting edge research challenges.
